% | $
Quotes you view appear here for quick access.

Muscle Pharm Corp. Message Board

  • aayoung Jul 19, 2013 6:03 PM Flag

    Q2 & Q3 v. Q4

    I wouldn't get too excited about massive growth in Q2 & Q3 as the management has already said Q1 & Q4 are their busiest quarters for sales. Basically, sales from these slow Q's will probably not be astoundingly different than Q1, and may even be a bit less as an organic fact of the business cycle.

    I'm still very positive on this company, despite the fairly large stock gift options given to management this year. I expect them (as "key employees") to bring us much more in value than what they have received. At least the stock compensation may motivate their activities in alignment with other shareholder interests. They have said shareholder value is important to them (now.) We'll see I guess.

    Assuming they have 10mil shares outstanding by the end of this year, the market cap would be about 110mil if the price were to remain at 11/share. Do you think a company with 105mil in revenue and likely on the verge of having a net profit deserves a market cap of 1 X sales?

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • They have some big shots on their board, that have been with Fortune500 cos in the past, so I think you are right to assume they will start to do what is in the best interest for shareholders as well as grow the company.
      People were freaking out about the stock options - every company offers them, and 10% of a new company to be owned by the insiders isnt uncommon.
      I think Q3 and Q4 will be 30million+ quarters for MSLP being is that they will get alot of people buying the new products. Ive said all along, I think 110-115million in sales is reasonable for this year, I think a small increase in sales in Q2 will be just fine as long as the cash burn wasnt bad.
      I think $15 by the end of the year is a conservative target, Im thinking up near 17-18 is Q2 earnings are inline.

      Sentiment: Buy

1.97+0.02(+1.03%)Oct 26 3:11 PMEDT